Trump administration officials say changes to federal agencies engaged in science were made in the interests of better science that benefits more Americans. Many scientists we spoke with disagree.
The biotech firm focused on fighting breast cancer was recently selected to the prestigious Charles River Cell & Gene Therapy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback